TORC1 Antibodies

Santa Cruz Biotechnology delivers a wide array of TORC1 monoclonal antibodies for advanced research in cellular signaling pathways. TORC1 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TORC1, or Target of Rapamycin Complex 1, plays a critical role in regulating cell growth, proliferation, and metabolism in response to nutrient availability and growth factors. TORC1 dysregulation is implicated in various diseases, including cancer and metabolic disorders, making it a significant target for therapeutic intervention. Understanding the function and regulation of TORC1 is essential for elucidating the mechanisms underlying these conditions. Researchers worldwide rely on TORC1 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. TORC1 monoclonal antibodies enable detailed analysis of protein interactions and signaling cascades. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies.